Mr. President, I rise today to introduce legislation to ensure that the land on the West Los Angeles Veterans Affairs, West LA VA, campus is protected for the use of America's Veterans. The bill…
Mr. President, I rise today to introduce legislation to ensure that the land on the West Los Angeles Veterans Affairs, West LA VA, campus is protected for the use of America's Veterans.
The bill would: require the VA Secretary to provide the Congressional Appropriations and Veterans Committees a comprehensive report regarding the master plan for the West LA VA facility and connected property.
The VA was required under Public Law 105-368 to develop a master plan for the West LA VA property.
If the VA has failed to developed the plan, the legislation requires it to complete a master plan prior to implementing any action based on the Capital Asset Realignment for Enhanced Services (CARES) initiative.
The VA would be prohibited from issuing any enhanced-use lease agreements for the West LA VA property until the master plan is completed and submitted to Congress.
Prevent the VA Secretary from implementing any portion of the master plan until 120 days after the submission of the plan to the Appropriations and Veterans Committees.
In addition, the Secretary would be expressly prohibited from pursuing development initiatives regarding the West LA VA property not relating to direct Veterans services unless explicitly authorized by Congress through legislation.
Direct Veterans services are defined in this legislation as any services ``directly related'' to maintaining the health, welfare, and support of Veterans.
Last year, the Senate approved similar language in the FY07 MILCON/VA Appropriations bill that required the VA to provide the Appropriations Committees a report on the master plan for the West LA VA Medical Center and connected land.
The fiscal year 2007 MILCON/VA Appropriations Act passed the Senate on November 18, 2006.
Unfortunately, all but 2 of the 11 Appropriations bills--including MILCON/VA--were ultimately packaged together in a Continuing Resolution for fiscal year 2007, and the language was never considered by the full Congress.
The bill I am introducing today is absolutely essential in light of a number of unacceptable actions that have previously been taken by the VA that, in my view, violate the spirit, if not the letter, of the law.
Last month, I joined with my colleagues Senator Barbara Boxer and Congressman Henry Waxman in writing a letter to VA Secretary James Nicholson strongly objecting to recent decisions by the VA relating to the West LA VA facility and land.
Over the past year alone, the VA has permitted the construction of a facility for the Fox Entertainment Group on the West LA VA property, and has approved a lease agreement with Enterprise Car Rental to operate on the campus.
In addition, the VA has allowed the Westside Shepherd of the Hill Church to rent a building on the property in which to hold its Sunday services and provided additional housing space for the University of California-Los Angeles (UCLA).
The VA reportedly has also considered lease projects such as movie productions, a drive-in theather, a circus event, and a golf course.
This must be put to a stop and the legislation I introduce today would do just that.
For too long, commercial interests have trumped the needs of our Veterans.
These 400 acres of land were donated to the government in 1888 specifically for Veterans and should remain that way--just as then-VA Secretary Anthony Principi promised during a visit to Los Angeles in February 2002.
I ask unanimous consent that the text of this legislation be printed in the Record.
Mr. President, I am pleased to introduce this bill today along with Senator Boxer as cosponsor to direct the Secretary of the Interior to study the suitability and feasibility of expanding the Santa Monica National Recreation Area to include the Rim of the Valley Corridor.
The Rim of the Valley Corridor is an example of a highly threatened habitat area, the Mediterranean chaparral ecosystem. Connecting to the adjacent Los Padres and San Bernardino National Forests, the Corridor encircles the San Fernando Valley, La Crescenta, Simi, Conejo, and Santa Clarita Valleys, consisting of parts of the Santa Monica Mountains, Santa Susanna Mountains, San Gabriel Mountains, Verdugo Mountains, and San Rafael Hills.
There is a great need for expanded parkland in southern California. While the Los Angeles metropolitan region has the second-largest urban concentration in the United States, the area has one of the lowest ratios of park-and-recreation-lands per thousand-population of any urban area in the country.
Since the creation of the Santa Monica Recreation Area in 1978, Federal, State, and local authorities have worked successfully together to create and maintain the highly successful Santa Monica Mountains National Recreation Area, hemmed in on all sides by development.
With the passage of this legislation, Congress will hold true to its original commitment to preserve the scenic, natural, and historic setting of the Santa Monica Mountains Recreation Area.
With the inclusion of the Rim of the Valley Corridor in the Santa Monica Mountains Recreation Area, greater ecological health and diversity will be promoted, particularly for larger animals like mountain lions, bobcats, and the golden eagle. By creating a single contiguous Rim of the Valley Trail, people will enjoy greater access to existing trails in the Recreational Area.
Within a National Recreation Area, the National Park Service is prohibited from exercising the powers of eminent domain, and private property may be purchased from voluntary sellers only.
The bill includes a provision directing the Department of the Interior to analyze any effects that a proposed expansion of the Santa Monica Mountains National Recreation Area will have on private land within or bordering the area. Any such effects will be thoroughly considered as the study moves forward.
After the study called for in this bill is complete, the Secretary of the Interior and Congress will be in a key position to determine whether all or portions of the Rim of the Valley Corridor warrant inclusion in the Santa Monica Mountains National Recreation Area.
This bill enjoys strong support from local and State officials and I hope that it will have as much strong bipartisan support this Congress, as it did last Congress. Congressman Adam Schiff plans to introduce companion legislation for this bill in the House and I applaud his commitment to this issue.
I urge my colleagues to support this legislation and I ask unanimous consent that the text of this proposed legislation be printed in the Record.
Mr. President, I rise today to introduce legislation to authorize water recycling and other water supply projects by the Inland Empire Utilities Agency and the Cucamonga Valley Water District. These projects will produce approximately 95,000 acre-feet of new water annually in one of the most rapidly growing regions in the United States, reducing the need for imported water from the Colorado River and northern California through the California Water Project.
The federal investment required is limited to approximately 10 percent of the projects' cost, or about $30 million.
This legislation is intended to be the companion to H.R. 122, sponsored by David Dreier, Grace Napolitano, Ken Calvert, Joe Baca, and Gary Miller.
This legislation has broad support and has already passed the House, and in fact similar legislation to H.R. 122 also passed the House of Representatives in each of the previous two Congresses.
It is time for this legislation to pass the Senate as well and be enacted into law. Environmental groups such as the Mono Lake Committee, Environmental Defense, Clean Water and Natural Resources Defense Council strongly support the water recycling and groundwater remediation projects in this bill. Business leaders such as Southern Cal Edison and Building Industry Association also support these projects.
The Inland Empire Regional Water Recycling Initiative would authorize two project components. The first will be constructed by the Inland Empire Utilities Agency--IEUA--and will produce approximately 90,000 acre feet of new water annually. The second of these projects, to be constructed by the Cucamonga Valley Water District--CVWD--will produce an additional 5,000 acre feet of new water annually.
The Inland Empire Regional Water Recycling Initiative has the support of all member agencies of IEUA, as well as the water agencies downstream in Orange County. IEUA encompasses approximately 242 square miles and serves the cities of Chino, Chino Hills, Fontana--through the Fontana Water Company--Ontario, Upland, Montclair, Rancho Cucamonga-- through the Cucamonga Valley Water District--and the Monte Vista Water District.
I want to say a few words about the importance of water recycling projects.
The development of recycled water can bring significant amounts of water ``on line'' in a relatively short period of time. Recycled water provides our State and region with the ability to ``stretch'' existing water supplies significantly and in so doing, minimize conflict and address the many needs that exist. According to the State of California's Recycled Water Task Force, water recycling is a critical part of California's water future with an estimated 1.5 million acre- feet of new supplies being developed over the next 25 years.
Water recycling is also a bipartisan initiative in California, as witnessed by the many Republican and Democratic House cosponsors of the House versions of the bill I introduce today.
Water recycling also has significant greenhouse gas reduction benefits. The greenhouse gas emission reductions attributed to local development and use of recycled water within Inland Empire Utilities Agency's service area is roughly 100,000 tons of CO2 equivalents per year.
With only a small percentage of the total recycled water available being used in Southern California, approximately 10 percent, there is a huge potential for additional energy savings and greenhouse gas reductions from aggressive development of recycled water supplies.
California is not the only State engaged in water recycling. Today, water recycling is an essential water supply element in Albuquerque, Phoenix, Denver, Salt Lake City, Tucson, EI Paso, San Antonio, Portland, and other western metropolitan areas.
I urge my colleagues to support this bill to help meet the West's water supply needs and to reduce our dependence on the Colorado River. I ask unanimous consent that the text of the bill be printed in the Record.
Mr. President, I rise, along with my Senate Cancer Coalition cochair, Senator Brownback, to introduce the National Cancer Act of 2007, a bipartisan blueprint for winning the war against cancer.
It includes: grants for targeted drug development; creating ``cancer quarterbacks'' in Medicare; Medicaid coverage for smoking cessation treatments; pilot projects for expanding colorectal cancer screening in underserved populations; continued research into the possible benefits of early detection for lung cancer; loan repayment assistance for cancer prevention researchers; incentives for research into drugs that
prevent cancer from developing and spreading in the first place; provisions to promote the collection and storage of tissue sample, to give researchers the tools they need to use genomic research to create individualized cures; promoting access to clinical trials, as well as investigational therapies for those who are terminally ill; addressing the health needs of the growing number of cancer survivors.
Just over 35 years ago, President Nixon signed into law the original National Cancer Act, creating the National Cancer Institute and making cancer research a priority of the Federal Government. This work has led to tremendous breakthroughs against cancer, including innovative drugs, treatments, and a better understanding of the factors that lead to cancer in the first place. Last year, death rates decreased for 11 of the 15 cancers most common in men, and 10 of the cancers most common in women.
Sixty-five percent of people diagnosed with cancer can now expect to survive at least 5 years. This is good news. But it is not enough. The cost of cancer, in both human and economic terms, remains staggering.
An estimated 1,399,790 Americans were diagnosed with some form of cancer last year.
Approximately 1 of 3 women will develop cancer at some point in her lifetime; for men, the risk is slightly less than 1 in 2.
The National Institutes of Health estimated the overall cost of cancer in 2005 at $209.9 billion.
The price of inaction is too steep. Cancer is, first and foremost, a disease of aging. About 76 percent of cancer cases are diagnosed in patients at age 55 or older. If no fundamental changes are made, the aging of the Baby Boom generation will bring a 20 percent increase in cancer diagnoses.
In the face of these challenges, the National Cancer Institute, NCI, with broad support in the cancer community, set the ambitious goal of ending death and suffering from cancer by 2015. This goal has generated unprecedented excitement and unity, with over 80 Members of the United States Senate signing a letter in support of the effort.
It is time to reexamine and reorient our Nation's cancer policy to meet this ambitious goal. This does not mean that cancer will be eradicated by 2015. As our population ages, cancer will not go away. But we can change the meaning of a cancer diagnosis, and that is what the 2015 goal is about.
Meeting this goal will take a comprehensive approach. It requires detecting cancer earlier, before it spreads and becomes harder to treat. It requires targeted therapies, capable of killing cancer cells while leaving healthy cells intact. We must provide access to high quality cancer care for those who do get sick. We must also understand more about why people get cancer in the first place, and ways it can be prevented.
Our legislation takes a multifaceted approach to changing the very nature of a cancer diagnosis. The National Cancer Act of 2007 will do the following:
Authorize grants for the development of targeted drugs.
New drug therapies continue to lead us closer to the day in which cancer is a treatable, chronic condition controlled with a simple pill or injection. It has now been 5 years since the drug company Novartis won approval for Gleevec, a targeted drug that has saved the lives of countless patients with Chronic Myeloid Leukemia, CML.
Gleevec demonstrates the promise of this new kind of drug therapy. It blocks the enzymes that help cancer cells grow and divide, leaving healthy cells untouched. When this drug was first introduced, CML patients who were near death recovered and left the hospital. Yet it could not be determined if their remission would last, or if long-term use of this revolutionary drug would prove safe.
We now know that Gleevec is fulfilling this early promise. Before the advent of this drug, CML patients would often suffer a relapse after 2 or 3 years. But a recent study of CML patients taking Gleevec has demonstrated a remarkable 89 percent survival rate after 5 years. The cancer progressed to a more serious stage in only 7 percent of patients during this time period, and only 5 percent were forced to discontinue treatment because of side effects.
These results suggest that patients may be able to stay on Gleevec indefinitely, keeping this formerly deadly cancer under control while leading full and productive lives.
Targeted therapies are now offering hope to patients with many different kinds of cancer: Herceptin for some breast cancers, Iressa for those with small cell lung cancer, Avastin for colorectal cancer. Avastin can extend survival by interfering with the growth of blood vessels that feed the tumor, literally starving it.
These drugs are the future of cancer research. We need more drugs like Gleevec, which transform cancer from a killer to a controllable health condition. This legislation would authorize NCI to make grants to further develop these treatments.
To help with the development of targeted drugs, the bill also calls for the establishment of a task force on surrogate endpoints and biomarkers. They are the mechanisms for measuring the efficacy of cancer treatment at the molecular level, allowing doctors to precisely gauge how a patient is reacting to a treatment, or if a cancer is progressing.
Developing biomarkers for different types of cancer is an essential step, and our bill will establish a program to develop the biomarkers with the most immediate clinical promise.
The bill will also create special reimbursements for coordinating physicians, or ``cancer quarterbacks'' in Medicare. Successful cancer treatment is increasingly complex, reaching across the entire spectrum of the medical profession. It can involve lab tests, CT-scans, surgery, chemotherapy, and a full team of specialists who offer this care. Many patients have no single physician who can guide them through the complicated and sometimes contradictory course of cancer treatment, no professional to advise them what is best.
This bill would require Medicare to pay oncology doctors or nurses to become the overall managers of patients' care, in effect providing every cancer patient with a ``cancer quarterback'' physician to help them coordinate care and make the necessary decisions.
This cancer quarterback can direct care in the manner that best meets the patient's needs, instead of focusing on only a small segment of his or her care.
This legislation requires that State Medicaid drug programs cover smoking cessation treatments in the same manner as all other approved therapies. I have long believed that we will not truly address the burden of cancer until we address tobacco use. I have asked all kinds of cancer experts about what we can do to stop death from cancer, and their answer is always the same: Stop tobacco use.
Tobacco causes 30 percent of cancer deaths and 1 in 5 of all deaths in the United States. It is the leading cause of preventable death. Smoking related costs total $167 billion annually.
According to the CDC, more than 70 percent of American smokers would like to quit. Studies indicate that tobacco use treatment, including smoking cessation aids, will double their chances of success.
Yet under current law, State Medicaid programs are exempted from providing coverage of smoking cessation agents in the same way as they provide coverage of other drugs. Other exemptions include fertility treatments, drugs to promote hair growth, and drugs for erectile dysfunction.
Simply put, smoking cessation aids, which are FDA approved and proven to be effective, do not belong on this list. Denying people access to treatments to help them break a deadly and expensive addiction is flawed policy.
Our bill will remove tobacco cessation products from this list of exemptions, leveling the playing field with other FDA approved products.
Our bill establishes pilot projects for expanding colorectal cancer screening for low-income, uninsured individuals. The Breast and Cervical Cancer Early Detection Program has proven very successful in providing low income women with access to potentially life saving screenings. It is now time to provide similar access to colorectal cancer screening.
The need is great. A 2006 study conducted by Northwestern University researchers found that only 7 percent of minority patients without regular
health care access at risk for developing colon cancer are being screened. A 2005 study of New York City residents found that those least likely to have been recommended colorectal screening are low- income or uninsured.
Early detection allows physicians to identify patients with pre- cancerous polyps, and treat them before cancer even develops. These pilot projects identify the best ways to provide access to this lifesaving care for those who are not currently receiving recommended screenings.
This bill will authorize continued research on the potential of CT scans to detect lung cancer early. before it becomes fatal. Despite all the promising advances against many types of cancer, lung cancer remains the Nation's leading cause of cancer death in both men and women. About 20,000 people who have never smoked are diagnosed with lung cancer each year, and this number is increasing.
We need to learn more about how to screen for lung cancer and detect it early, before it has advanced. There is much we need to learn before scientists can make a definitive recommendation about screening and its potential benefits for both smokers and non-smokers.
To help scientists learn more, this bill will authorize funding to provide CT scans to those with a history of heavy smoking. This further study will help determine whether this promising technology is indeed the method we need to make progress against the leading cancer killer.
This legislation expands the existing NIH loan repayment program to provide assistance to researchers who make a commitment to working on cancer prevention research. This will encourage the best and brightest to pursue work that will help us to better understand what causes cancer and how we can stop it from occurring.
The bill will encourage and support research into new drugs and treatments, called chemopreventatives, which can stop precancerous cells from becoming tumors. Decades of research has enabled physicians to prescribe medications to prevent serious illness, such as statin drugs to lower cholesterol, and drugs to treat high blood pressure before it leads to strokes.
Progress in drug development to stop cancer has been far more limited. The promise of this field was made clear when, last year, the Food and Drug Administration, FDA, licensed Gardasil, a vaccine to stop the spread of cervical cancer. Gardasil protects against the two forms of the human papillomavirus, or HPV, which causes approximately 70 percent of cervical cancer cases. This vaccine could virtually eliminate cervical cancer during the lifetime of our daughters and granddaughters.
We need more chemoprevention techniques like Guardasil to guard against other types of cancer. People at high risk for a specific type of cancer may one day take a daily pill to stop abnormal cells from progressing to full blown cancer. Though it will take a long time for these promises to become reality, this research is the future of cancer care.
In order to encourage this work, our legislation would grant Orphan Drug Act protections to treatments designed to treat high-risk conditions in individuals who have not yet been diagnosed with cancer, but if left untreated, face a high risk of developing cancer.
This research will require new resources in order to have the best chance of success. To build the foundations for success, our bill will encourage biospecimen collection.
Scientists are beginning to understand the significant role that genetics plays in the development of cancer. To encourage further study, scientists need access to a variety of tissue, blood, and other samples from both cancer patients and those who are healthy. Our bill codifies guidelines for the collection of these samples and requires that the Medicare Payment Advisory Commission, MedPAC, draft a report examining potential payment systems for these activities.
We are on the cusp of an age of personalized medicine, in which a cancer patient's tumor can be analyzed to determine what type of treatment will be most effective. Patients will no longer undergo round after round of chemotherapy or radiation in the hopes of finding a treatment regime that works. Collecting and storing blood and tissue samples will provide our researchers with the materials they need to make these important discoveries.
Our bill will promote clinical trial enrollment. Patients willing to try these cutting edge cancer therapies as they emerge face a variety of obstacles. They, or their physicians, might not know what clinical trial opportunities exist. They may need to travel to a far away facility to participate. Our legislation requires the Director of the National Cancer Institute to create a clinical trials program, which includes: an outreach program, to assure that all patients, especially minorities, participate in trials; and a coordination program, to help patients with logistical challenges and the support costs of trial participation.
Our bill creates an oncology compassionate access program. No patient should lose a battle with cancer because bureaucratic hurdles denied him or her access to a potentially lifesaving therapy. Our bill provides for the creation of a new compassionate access program to speed access of investigational therapies for terminally ill patients who have exhausted all other available treatment options.
Our bill will address the needs of a growing number of cancer survivors. As cancer increasingly becomes a manageable, chronic condition, there will be an increasing number of cancer survivors confronting yet-unknown health challenges. Current cancer survivors number almost 10 million, and this number will only grow. This bill will: expand current cancer surveillance systems to track the health status of cancer survivors; implement a national cancer survivorship action plan, including post treatment health programs; require States to consider the needs of cancer survivors, and their families, in addition to current patients, when drafting their comprehensive cancer control plans.
Require the National Cancer Institute and the National Institute of Environmental Health Sciences, NIEHS, to report on their strategies, benchmarks, and progress in meeting the 2015 goal. This will allow Congress to adjust policy as necessary to ensure that the promise of ending death and suffering from cancer is realized.
The state of cancer care has changed drastically since 1971, and it is time that our Federal policies reflect these changes. The 2015 goal is ambitious, and it requires no less than ambitious legislation in response.
I urge you to join me in supporting this legislation.
Mr. President, I rise today with Senators Collins and Snowe to introduce legislation that will significantly reduce the amount of greenhouse gases emitted from our Nation's transportation sector.
This bill would reduce carbon dioxide emissions from passenger vehicles and motor vehicle fuels by 22 percent below projected levels under business as usual by 2030. This reduction is equivalent to the removal of 662 million metric tons of carbon dioxide from the atmosphere or taking over 108 million cars off the road for a year. This would save 3.6 million barrels of oil per day by 2030.
It would achieve these reductions by requiring a: 3 percent reduction in emissions from the motor vehicle fuel pool by 2015, with an additional 3 percent reduction every 5 years, and 30 percent reduction in vehicle tailpipe emissions by 2016, with additional reductions every 5 years.
Highway vehicles are responsible for 32 percent of annual U.S. emissions of carbon dioxide (CO2), the primary global- warming gas. And, motor vehicle emissions will continue to increase as more and more Americans purchase vehicles and the number of miles driven grows.
With more than 240 million motor vehicles on the road, producing 2 billion metric tons of carbon dioxide emissions per year, increasing our use of low carbon fuels is an essential part of a climate-safe transportation strategy.
So, the signs could not be clearer: It's time to sound the death- knell for the era of gas-guzzling motor vehicles. It is time to utilize improved vehicle technology and to increase access to cleaner, renewable fuels at the pump.
First, this bill will achieve this goal by increasing the availability of low carbon emitting fuels for motor vehicles.
We must start considering fuel emissions not only in terms of emissions produced at the tailpipe, but also in terms of the emissions generated by the production and transportation of fuels. The total emissions of a fuel,
from production to end-use, are known as the ``lifecycle emissions'' of a fuel.
Not all fuels are created equal in terms of emissions; in fact, not all fuels within a give fuel category are created equal.
For example, ethanol produced from corn emits only about 10 to 20 percent less greenhouse gas emissions per unit of energy delivered compared to petroleum-based gasoline. In contrast, ethanol produced from cellulosic biomass achieves an 80 to 90 percent reduction in greenhouse gas emissions per unit of energy.
Electricity would also qualify as an alternative fuel under this bill. The lifecycle emissions of electricity produced by traditional coal-fired power plants will be far greater than that produced by wind or other zero-carbon electricity generation technologies.
By 2009, this bill would require the Environmental Protection Agency (EPA) to quantify the total lifecycle emissions of all motor vehicle fuels. The bill would also require EPA to develop a fuel labeling process to provide this information to consumers at the pump.
Armed with this information about the lifecycle emissions of different fuels, oil refiners and importers would be required to reduce the greenhouse gas emissions of their entire fuel pool by 3 percent below projected levels by 2015. And, every 5 years thereafter, emissions would be cut by an additional 3 percent.
To help fuel providers meet the mandated emissions reductions in a cost-effective manner, the bill would establish a carbon-credit trading market.
This would reduce emissions from motor vehicle fuels by 10 percent below projected levels by 2030 and would increase the supply of low- carbon fuels such as biodiesel, E-85, hydrogen, electricity, and others.
Second, the bill would achieve reductions in transportation sector emissions by federalizing California's landmark tailpipe emissions standard. California passed a landmark law in 2002 that required a reduction in tailpipe emissions and was the first State in the country to do so. This would require automakers to reduce tailpipe emissions, such as carbon dioxide, by 30 percent by 2016. It will also require EPA to tighten the reductions every 5 years.
Combined, these provisions would achieve a 22 percent reduction in transportation sector emissions below projected levels by 2030.
Additional provisions in the bill mandate: auto manufacturers to optimize dual-fueled vehicles to improve their fuel economy when running on alternative fuels, and alternative fuel vehicles, and only alternative fuel vehicles, come with a green fuel cap. This would alert consumers that these vehicles can accept other fuels besides traditional gasoline.
Just as it is necessary to reduce emissions in the electricity and industrial sectors, it is equally necessary to reduce emissions from the transportation sector. This bill makes significant, yet feasible, strides to reduce emissions through upgrades in vehicle technology and the incorporation of lower lifecycle emission fuels into the motor vehicle fuel pool. I urge my colleagues to join me in supporting this bill.
I ask unanimous consent that the text of the legislation be printed in the Record.